Palfrey Health Centre is a Research Active Practice.
We are always looking for ways to improve your care and where possible access new and novel treatments.
We partner with NHS National Institute for Health and Care Research (NIHR) to help gather the information that helps save lives.
If you could be suitable for a study, we may get in touch to let you know.
Together we can improve the lives of people with diabetes, cancer, dementia.
If you rather we didn’t contact you please tell the practice team, and we’ll update your records.
Palfrey Health Centre is certified Research Ready by the Royal College of General Practitioners
NIHR Clinical Research Network West Midlands
MIBOKO Study
The purpose of this study is to assess the usage of the Miboko devise by patients who are obese as an
aid to reduce weight, manage their health and reduce their risk of developing diabetes.
For more information Miboko Study
MAVIS Study
This study aims to understand women’s experiences of being offered vaccinations in pregnancy. Your participation could help improve women’s care and the equality of vaccination provision across England. It involves an anonymous online survey, or talking to a researcher about your experiences.
For more information MAVIS
LOLIPOP 100K study
The purpose of this study is to improve our understanding of the causes of heart disease, diabetes
and cancer, as well as many other important ‘chronic conditions’ such as asthma, visual impairment,
memory loss and obesity. We are trying to work out why some people, but not others, develop these
health problems
For more information LOLIPOP
MAGNIFY
It is believed that poor adherence to prescribed medications is high in patients with Chronic Obstructive Pulmonary Disease (COPD), this can be attributed to several factors, including forgetting to take medication, incorrect inhaler usage and perception of patient’s of their illness. NICE guidelines have noted the importance of supporting patients with their regular inhaler use as part of COPD management. Non-adherence to prescribed medications can lead to poor clinical outcomes for patients.
Electronic reminders and monitoring have been used in several disease conditions to improve medication adherence. MAGNIFY will enable GP practices to support regular inhaler use through a new technology. This technology includes a device which is attached to a bespoke inhaler. This device monitors inhalations and sends reminders to the user’s smartphone to take their daily dose. The study aims to determine whether the use of adherence support technology will improve outcomes in COPD patients with poor adherence to treatment.
For more information MAGNIFY